InsidersTradesSigma
Atlanta Braves Holdings, Inc.: insider trades · United States · SEC (Form 4)
Discover the full management transaction log of Atlanta Braves Holdings, Inc., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €3.1bn. The latest transaction was filed on 2 December 2025 (Levée d'options). Among the most active insiders: MALONE JOHN C. Every trade is openly available.
74
Insider Decl.
0
Thresholds
€9m
27 ops.
Buy Volume
€2m
6 ops.
Sell Volume
34Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 2 December 2025
Declarations74 total
20,000 shares@ US$27.1813.1% of flowSeries C Common StockSEC:0001104659-25-117693:0
20,000 shares@ US$39.45919.0% of flowSeries C Common StockSEC:0001104659-25-117693:1
31,431 shares@ US$41.9513.7% of flowSeries A Common StockSEC:0001104659-25-109118:0
Ideal exit: 3 Aug 2026 (T+270)
23,200 shares@ US$41.95810.1% of flowSeries A Common StockSEC:0001104659-25-109118:1
Ideal exit: 4 Aug 2026 (T+270)
500 shares@ US$45.3521.8% of flowSeries A Common StockSEC:0000807249-25-000137:0
40,000 shares@ US$27.1826.0% of flowSeries C Common StockSEC:0001104659-25-080244:0
40,000 shares@ US$43.8241.9% of flowSeries C Common StockSEC:0001104659-25-080244:1
767 shares@ US$40.97100.0% of flowSeries C Common StockSEC:0001104659-25-049667:0
25,000 shares@ US$27.1848.4% of flowSeries C Common StockSEC:0001104659-25-048476:0
8,371 shares@ US$41.943.7% of flowSeries A Common StockSEC:0001104659-25-038097:0
Ideal exit: 16 Jan 2026 (T+270)
25,182 shares@ US$41.9111.1% of flowSeries A Common StockSEC:0001104659-25-036337:0
Ideal exit: 11 Jan 2026 (T+270)
3,609 shares@ US$41.991.6% of flowSeries A Common StockSEC:0001104659-25-035488:0
Ideal exit: 9 Jan 2026 (T+270)
44,258 shares@ US$41.8019.7% of flowSeries A Common StockSEC:0001104659-25-034726:0
Ideal exit: 5 Jan 2026 (T+270)
38,452 shares@ US$40.2816.9% of flowSeries A Common StockSEC:0001104659-25-033737:0
Ideal exit: 3 Jan 2026 (T+270)
1,135 shares@ US$42.000.5% of flowSeries A Common StockSEC:0001104659-25-025046:0
Ideal exit: 9 Dec 2025 (T+270)
2,760 shares@ US$41.991.3% of flowSeries A Common StockSEC:0001104659-25-023994:0
Ideal exit: 7 Dec 2025 (T+270)
25,000 shares@ US$27.1851.6% of flowSeries C Common StockSEC:0001104659-25-020865:0
24,646 shares@ US$41.9411.9% of flowSeries A Common StockSEC:0001104659-25-008091:0
Ideal exit: 26 Oct 2025 (T+270)
5,094 shares@ US$41.942.4% of flowSeries A Common StockSEC:0001104659-25-007190:0
Ideal exit: 24 Oct 2025 (T+270)
15,192 shares@ US$40.627.1% of flowSeries A Common StockSEC:0001104659-25-005976:0
Ideal exit: 19 Oct 2025 (T+270)
2,000 shares@ US$39.188418.1% of flowSeries A Common StockSEC:0000807249-25-000007:0
Ideal exit: 7 Oct 2025 (T+270)
73,334 sharesSeries C Common StockSEC:0001104659-25-000767:0
265,000 shares0Series C Common StockSEC:0001104659-24-131410:0
265,000 shares0Series C Common StockSEC:0001104659-24-131410:1
30,084 shares0Series C Common StockSEC:0001104659-24-128470:0
25 of 74 declarations